Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 67, Issue 1, 2010, Pages 110-117

  Ramakrishna, Rohan ^a   Sekhar, Laligam N ^a   Ramanathan, Dinesh ^a   Temkin, Nancy ^a   Hallam, Danial ^a   Ghodke, Basavaraj V ^a   Kim, Louis J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hydrocephalus; Subarachnoid hemorrhage; Thrombolysis; Tissue plasminogen activator; Vasospasm

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANGIOPLASTY; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYDROCEPHALUS; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR; VASOSPASM, INTRACRANIAL;

EID: 77954134712     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000370920.44359.91     Document Type: Article

References (65)

1. Le Roux PD, Elliott J P, Newell DW, Grady MS, Winn HR. Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurgery. 1996;85(1):39-49.
2. Fisher CM, Kistler J P, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1981; 6(1):1-9.
3. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59(1):21-27.
4. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101(2):255-261.
5. Vale FL Bradley EL, Fisher WS 3rd. The relationship of SAH and the need for postoperative shunting. J Neurosurgery. 1997;86(3):462-466.
6. Schmieder K, Koch R, Lucke S, Harders A. Factors influencing shunt dependency after aneurysmal SAH. Zentralbl Neurochir. 1999;60(3):133-40.
7. Sheehan J P, Polin RS, Sheehan JM, Baskaya MK, Kassell N F. Factors associated with hydrocephalus after aneurysmal SAH. Neurosurgery. 1999;45:1120-1127.
8. Graff-Radford NR, Torner J, Adams H P, Kassell N F. Factors associated with hydro-cephalus after SAH: a report of the Cooperative Aneurysm Study. Arch Neurol. 1989;46(7):744-752.
9. Dorai Z, Hynan LS, Kopitnik TA, Samson DS. Factors related to hydrocephalus after aneurysmal SAH. Neurosurgery. 2003;52(4):763-769.
10. Ohwaki K, Yano E, Nakagomi T, Tamura A. Relationship between shunt dependent hydrocephalus after SAH and duration of CSF drainage. Br J Neurosurgery. 2004;18(2):130-134.
11. Yoshioka H, Inagawa T, Tokuda Y, Inokuchi F. Chronic hydrocephalus in elderly patients following SAH. Surg Neurol. 2000;53(2):119-124.
12. Findlay JM, Weir BK, Kassell N F, Disney LB, Grace MG. Intracisternal recombi-nant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurgery. 1991;75(2):181-188.
13. Findlay JM, Kassell N F, Weir BK, et al. A randomized trial of intraoperative cister-nal tissue plasmingen activator for prevention of vasospasm. Neurosurgery. 1995; 37(1):168-178.
14. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue type plasminogen activator. J Neurosurgery. 1993;78(3):430-437.
15. Sasaki T, Ohta T, Kikuchi H, et al. A phase II clinical trial of recombinant tissue type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1994;35(4):597-605.
16. Sasaki T, Kodama N, Kawakami M, et al. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system. Stroke. 2000;31(6):1256-1262. (Pubitemid 30351242)
17. Ohman J, Servo A, Heskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurgery. 1991;75(2):197-201.
18. Seifert V, Stolke D, Zimmerman M, Feldges A. Prevention of delayed ischemic deficits after aneursymal subarachnoid hemorrhage by intrathecal bolus injection of tissue type plasminogen activator. Acta Neurochir (Wien). 1994;128(1-4):137-143.
19. Steinberg G, Vanefsky MA, Marks M P, Adler JR, Joenig GH. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 1994;34(5):809-814.
20. Usui M, Saito N, Hoya K, Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery. 1994;34(2):235-245.
21. Zabramski JM, Spetzler R F, Lee KS, et al. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurgery. 1991;75(2):189-196.
22. Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery. 2004;55(3):532-537.
23. Varelas PN, Rickert KL, Cusick J, et al. Intraventricular hemorrhage after aneurys-mal SAH: pilot study of treatment with intraventricular TPA. Neurosurgery. 2005;56(2):205-213.
24. Todo T, Usui M, Takakura K. Treatment of intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurgery. 1991;74(1):81-86.
25. Mayfrank L, Lippitz B, Groth M, Bertalanffy, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe IVH. Acta Neurochir (WIen). 1993;122(1-2):32-38.
26. Rohde V, Schaller C, Hassler W. Intraventricular recombinant tissue plasminogen activator for lysis of IVH. J Neurol Neurosurg Psych. 1995;58(4):447-451.
27. Mayfrank L, Rohde V, Gilsbach JM. Fibrinolytic treatment of IVH preceding surgical repair of ruptured aneurysms and AVMs. Br J Neurosurgery. 1999;13(2):128-131.
28. Azmi-Ghadimi H, Heary R F, Farkas JE, Hunt CD. Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports. Neurosurgery. 2002;50(2):421-424.
29. Kodama N, Sasaki T, Kawakami M, Sato M, Asari J. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol. 2000;53(2):117-118.
30. Inagawa T, Yamamoto M, Kamiya K. Effect of clot removal on cerebral vasospasm. J Neurosurgery. 1990;72:224-230. (Pubitemid 20087711)
31. Ljunggren B, Säveland H, Brandt L, Zygmunt S. Early operation and overall outcome in aneurysmal SAH. J Neurosurgery. 1985;62(4):547-551.
32. Mizukami M, Kawase T, Usami T, Tazawa T. Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery. 1982;10(3):301-307.
33. Suzuki J, Kodama N, Yoshimoto T, Mizoi K. Ultra-early surgery of intracranial aneurysms. Acta Neurochir (WIen). 1982;63(1-4):185-191.
34. Taneda M. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurgery. 1982;57(5):622-628.
35. Natarajan SK, Sekhar LN, Ghodke B, Britz G, Bhagwati D, Temkin N. Outcomes of ruptured intracranial aneurysms treated by microsurgical clipping and endovascu-lar coiling in a high-volume center. AJNR Am J Neuroradiol. 2008;29(4):753-759.
36. Mckhann GM, Mayer S, Ke Roux P. Perioperative and ICU Care of Patients with Aneurysmal Subarachnoid Hemorrhage. Philadelphia: Elsevier Science; 2004.
37. Aaslid R, Huber P, Nornes H. A transcranial Doppler method in the evaluation of cerebrovascular spasm. Neuroradiology. 1986;28(1):11-16. (Pubitemid 16146458)
38. Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular vasospasm with tran-scranial Doppler ultrasound. J Neurosurg. 1984;60(1):37-41.
39. Sloan MA, Burch CM, Wozniak MA, et al. Transcranial Doppler detection of vertebrobasilar vasospasm following SAH. Stroke. 1994;25(11):2187-2197.
40. Sloan MA, Haley EC Jr, Kassell N F, et al. Sensitivity and specificity of transcra-nial Doppler ultrasonography in the diagnosis of vasospasm following SAH. Neurology. 1989;39(11):1514-1518.
41. Burch CM, Wozniak MA, Sloan MA, et al. Detection of intracranial internal carotid artery and middle cerebral artery vasospasm following SAH. J Neuroimaging. 1996;6(1):8-15.
42. Wozniak MA, Sloan MA, Rothman MI, et al. Detection of vasospasm by transcranial Doppler sonography; the challenges of anterior and posterior cerebral arteries. J Neuroimaging. 1996;6(2):87-93.
43. Sviri GE, Ghodke B, Britz G W, et al. Transcranial Doppler criteria for basilar artery vasospasm. Neurosurgery. 2006;59(2):360-366.
44. Kincaid S. Transcranial Doppler ultrasonography: a diagnostic tool of increasing utility. Curr Opin Anaesthesiol. 2008;21(5):552-559.
45. Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62(9):1468-1481.
46. Kincaid MS, Souter MJ, Treggiari MM, Yanez ND, Moore A, Lam AM. Accuracy of transcranial Doppler ultrasonography and single-photon emission computed tomography in the diagnosis of angiographically demonstrated cerebral vasospasm. J Neurosurg. 2009;110(1):67-72.
47. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Inter-observer Agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
48. Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T. Prevention of symptomatic vasospasm after aneursymal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo). 2004;44(11):569-577.
49. Stolke D, Seifert V. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal SAH; preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery. 1992;30(6):877-881.
50. Asano T, Takakura K, Sano K, et al. Effects of a hydroxyl radical scavenger on delayed ischemic neurologic deficits following aneurysmal SAH: results of a multicenter, placebo-controlled double-blind trial. J Neurosurgery. 1996;84(5):792-803.
51. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K. The effect of lipid hydroperoxide of arachidonic acid on the canine basilar artery. J Neurosurg. 1981; 54(3):357-365.
52. Maeda Y, Hirano K, Hirano M, et al. Enhanced contractile response of the basilar artery to platelet derived growth factor in SAH. Stroke. 2009;40(2):591-596. Epub 2008 Dec 18.
53. Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal SAH: putative mechanisms and novel approaches. J Neurosci Res. 2009;87(1):1-11.
54. Biller J, Godersky JC, Adams H P. Management of aneurysmal SAH. Stroke. 1988; 19(10):1300-1305.
55. Dorsch N. Cerebral arterial spasm - a clinical review. Br J Neurosurgery. 1995;9(3):403-412.
56. Treggiarai-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal SAH: a problem of neurointensive care. Neurosurgery. 2001;48(2):249-261.
57. Komotar RJ, Hahn DK, Kim GH, et al. Efficacy of lamina terminalis fenestration in reducing shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a systematic review. J Neurosurg. 2009;111(1):147-154.
58. Park P, Garton HJ, Kocan MJ, Thompson BG. Risk of infection with prolonged ventricular catheterization. Neurosurgery. 2004;55(3):594-599; discussion 599-601.
59. Arabi Y, Memish ZA, Balkhy HH, et al. Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control. 2005;33(3):137-143.
60. Zwienenberg-Lee M, Hartman J, Ridisill N. Endovascular management of cerebral vasospasm. Neurosurgery. 2006;59(suppl 3):S139-S147.
61. Kwon O, Kim YJ, Kim Y, Sung Cho C, Koo Lee S, Ki Cho M. The utility of external lumbar CSF drainage after endovascular coiling on aneurysmal SAH. J Korean Neurosurg Soc. 2008;43(6):281-287.
62. Kasuya H, ShimiT, Kawaga M. The effect of continuous drainage of CSF in patients with SAH: a retrospective analysis of 108 patients. Neurosurgery. 1991;28(1):56-59.
63. Klimo P Jr, Kestle JR, Macdonald J, Schmidt R. Marked reduction of cerebral vasospasm with lumbar drainage of CSF after SAH. J Neurosurgery. 2004;100(2):215-224.
64. Ochiai H, Yamakava Y. Continuous lumbar drainage for the preoperative management of patients with aneurysmal SAH. Neurol Med Chir (Tokyo). 2001;41(12):576-580.
65. Jartti P, Karttunen A, Isokangas JM, Jartti A, Koskelainen T, Tervonen O. Chronic hydrocephalus after neurosurgical and endovascular treatment of ruptured intracranial aneurysms. Acta Radiol. 2008;49(6):680-686.